Antares Pharma Announces Notice of Allowance for New Patent on VIBEX™ QuickShot Device

Antares Pharma, Inc.

today announced that it has received a Notice of Allowance from the U.S. Patent Trade Office (USPTO) on a patent application for the VIBEX™ QuickShot (QS) device, the latest advancement in its proprietary line of VIBEX™ auto-injector systems.